ArticleIJID regions2025
Excess mortality during the first 2 years of the COVID-19 pandemic (2020-2021) in the Netherlands: Overall and across demographic subgroups.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dynamics of infection, vaccination and excess mortality during the COVID-19 pandemic among older individuals-a nationwide analysis.European journal of epidemiology · 2026Article
- The impact of policy restrictions and mobility changes on excess mortality during the COVID-19 pandemic in The Netherlands, 2020-2022.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The overall impact of the COVID-19 pandemic on mortality can be estimated by the assessment of excess deaths from all causes because the reported number of deaths due to COVID-19 do not accurately reflect the true death toll. We assessed excess mortality in 2020 and 2021 in the Netherlands. Methods: All analyses were performed on data from comprehensive nationwide registers provided by Statistics Netherlands (Centraal Bureau voor de Statistiek), including demographic characteristics and mortality. All-cause mortality incidence rates were calculated per calendar month and compared against COVID-19 infections and preventive strategies. The all-cause mortality incidence rate ratios (IRRs) with 95% confidence intervals (95% CIs) were estimated per calendar year using Poisson regression (overall and for subgroups). Results: Compared with predicted mortality based on 2019 rates, the overall excess mortality was 8.9% (IRR 1.089, 95% CI 1.081-1.097) in 2020 and 8.5% (IRR 1.085, 95% CI 1.077-1.092) in 2021. Relative excess mortality was higher for men, people with low household income, first-generation immigrants, and individuals living in extremely urbanized areas. In 2020, excess mortality was highest in age groups above 75 years (over 10%.); in 2021, it was clearly present even in the 20-39 years age group (6.6%). Conclusions: Our results quantify excess mortality during the first 2 years of the COVID-19 pandemic in the Netherlands. We show that the extent of excess mortality varies considerably across demographic groups, which may help in identifying target groups for preventive strategies during future health crises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.